Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...

Shelby Knowles/Bloomberg/Getty Images Zepbound outperformed Wegovy for weight loss in a ... more body weight reduction due to tirzepatide. By comparison, those who received semaglutide experienced ...

A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study ...

"This study allowed us to do a direct comparison." "The results are ... clinical trial programs and in SURMOUNT-5, both Wegovy and Zepbound have demonstrated clinically significant weight ...

By comparison, those who received ... “In real-world terms, that means many patients on Zepbound are losing more weight than those on Wegovy,” he noted. Dasgupta described the results of ...

Early-stage study results suggest that a single shot of the company’s therapy, which works differently than GLP-1 medicines, ...

Metsera is advancing promising obesity treatments with amylin and GLP-1 analogs, eyeing competitive efficacy and buyout ...